More Americans taking Ozempic will boost the US economy, Goldman says – By Megan Henney (FOX Business) / Feb 26, 2024
The more Americans that take Ozempic, the faster the US economy will grow, Goldman says
More widespread use of powerful weight-loss drugs like Ozempic in the U.S. could boost the economy in the coming years, according to Goldman Sachs strategists.
The bank estimates that weight-loss drugs, called GLP-1 agonists, could increase the nation’s gross domestic product by an extra 1% over the next decade, the equivalent of about $360 billion per year.
The thinking behind Goldman’s forecast is that poor health is a burden to economic growth, largely because it limits the number of available workers and hours worked due to increased missed days at work as a result of “sickness and disability, early deaths and informal caregiving.”
In fact, Goldman said that GDP in the U.S. would potentially be more than 10% higher if poor health outcomes did not affect the labor supply.
CONTINUE > https://www.foxbusiness.com/economy/more-americans-taking-ozempic-will-boost-us-economy-goldman-says
